Skip to main content

triamcinolone

Generic: TRIAMCINOLONE·Brand: ARISTOCORT, Aller-Cort, AllerNaze, Genesis, Hexatrione, KENACORT, Kenalog, Kourzeq, Nasacort, Oralone, TRIAMCINOLONE, Trianex, Triderm, Triesence, Tritocin, Xipere, Zilretta

triamcinolone: 5 clinical trials tracked.

triamcinolone evidence translation

What we can confirm

5 tracked trials

No verified listed developer

What it means

AI will separate confirmed drug evidence from unknown company context.

What to watch

Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected

Prepared research question

What is verified about triamcinolone, and what remains unknown?

Run cited research

Traceable citations · Unknowns marked

See linked entities and source evidence3 indications · 2 study sponsors
Clinical Trials (5)

Safety and Efficacy of Topical Bacteriotherapy for Atopic Dermatitis Using Staphylococcus Hominis A9

NCT06504160·Phase 1
Recruiting

Primary endpoint: Time to the first Atopic Dermatitis (AD) flare.

InterventionalRandomizedquadruple86 targetStarted 2025-05Completion 2027-028 sites · United StatesNational Institute of Allergy and Infectious Diseases (NIAID)

NSAID Injection Versus Corticosteroid Injection for Basilar Thumb Arthritis: A Randomized, Controlled Trial

NCT05992883·Phase 3·VALN
Recruiting

Primary endpoint: Visual Analogue Scale (VAS) of Pain

InterventionalRandomizeddouble240 targetStarted 2023-07Completion 2026-121 site · United StatesMayo Clinic

A Phase 2b, Randomized, Double-masked, Multicenter, Dose-ranging, Sham-controlled Clinical Trial to Evaluate Intravitreal JNJ-81201887 (AAVCAGsCD59) Compared to Sham Procedure for the Treatment of Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)

NCT05811351·Phase 2·CLSDQ
Active, not recruiting

Primary endpoint: Global: Change From Baseline in Square Root of Geographic Atrophy (GA) Lesion Area in the Study Eye at Month 18

InterventionalRandomizedtriple305 targetStarted 2023-03Completion 2026-1250 sites · United StatesJanssen Research & Development, LLC

Triamcinolone With Vitamin D Synergistic Efficacy in Psoriasis

NCT04036188·Early Phase 1·CLSDQ
Recruiting

Primary endpoint: Improvement in Psoriasis Area and Severity Score (PASI) from baseline

InterventionalRandomizeddouble24 targetStarted 2019-10Completion 2026-121 site · United StatesWright State University

Analysis of Antalgic Efficacy of an Intra Articular Injection of Botulinum Toxin Versus Corticoids in Gonarthrosis by Perfusion MRI:a Superiority, Randomized, Controlled, Double Blind Study

NCT03726788·Phase 2
Withdrawn

Primary endpoint: Assesment of vascularization by dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) according to the % Area Under the Curve (AUC) of perfusion value

InterventionalRandomizedquadruple0 targetStarted 2019-09Completion 2022-041 site · FranceLille Catholic University